These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 17890738
1. Clinical research of kidney diseases II: problems of study design. Ravani P, Parfrey PS, Dicks E, Barrett BJ. Nephrol Dial Transplant; 2007 Oct; 22(10):2785-94. PubMed ID: 17890738 [No Abstract] [Full Text] [Related]
2. How to read critically a prognostic cohort study. Palmer SC, Strippoli GF. Nephrology (Carlton); 2010 Oct; 15(7):676-82. PubMed ID: 21040162 [Abstract] [Full Text] [Related]
6. Long-term risk projection and its application to nephrology research. Turin TC, Hemmelgarn BR. J Nephrol; 2012 Sep; 25(4):441-9. PubMed ID: 22711434 [Abstract] [Full Text] [Related]
7. Propensity score methods and their application in nephrology research. Barnieh L, James MT, Zhang J, Hemmelgarn BR. J Nephrol; 2011 Sep; 24(3):256-62. PubMed ID: 21404223 [Abstract] [Full Text] [Related]
8. Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial? Weir MR, Bakris GL. Am J Nephrol; 2010 Sep; 31(5):469-70. PubMed ID: 20413964 [No Abstract] [Full Text] [Related]
10. Bias in surgical research. Paradis C. Ann Surg; 2008 Aug; 248(2):180-8. PubMed ID: 18650626 [Abstract] [Full Text] [Related]
11. Epidemiologic and clinical challenges of geriatric nephrology. Aucella F. J Nephrol; 2010 Aug; 23 Suppl 15():S1-4. PubMed ID: 20872363 [No Abstract] [Full Text] [Related]
12. [Nephrology evidence and guidelines: current tools and several still open questions]. Strippoli GF, Manno C, Schena FP. G Ital Nefrol; 2003 Aug; 20(3):271-9. PubMed ID: 12881850 [Abstract] [Full Text] [Related]
13. Debate: CON position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial? Glassock RJ. Am J Nephrol; 2010 Aug; 31(5):462-5; discussion 466-7. PubMed ID: 20413961 [No Abstract] [Full Text] [Related]
14. Enhancing clinical trial development for pediatric kidney diseases. Schnaper HW, Flynn JT, Gross C, Cropp AB, Dehmel B, Patel LB, Greenbaum LA, Houtsmuller E, Kaskel F, Moxey-Mims M, Nowak K, Silverstein D, Thompson A, Yao L, Darsey E, Smoyer WE. Pediatr Res; 2017 Nov; 82(5):727-732. PubMed ID: 28853726 [Abstract] [Full Text] [Related]
15. What can nephrologists learn from epidemiology? Elseviers MM, De Broe ME. J Nephrol; 2001 Nov; 14(2):88-92. PubMed ID: 11411019 [Abstract] [Full Text] [Related]
16. Assessment of problems: which study design? Elseviers M. EDTNA ERCA J; 1999 Nov; 25(3):23-6. PubMed ID: 10786490 [Abstract] [Full Text] [Related]
18. Intention and outcome in guideline-based nephrological practice: a suitable space for 'clinical technology'. Will E. Nephrol Dial Transplant; 2007 Nov; 22(11):3110-4. PubMed ID: 17720991 [No Abstract] [Full Text] [Related]
19. Clinical databases in nephrology: research and clinical practice goals and challenges. Zoccali C. J Nephrol; 2006 Nov; 19(5):551-5. PubMed ID: 17136681 [Abstract] [Full Text] [Related]
20. [Contribution of clinical epidemiology to evidence-based nephrology]. Frimat L. Nephrologie; 2001 Nov; 22(5):199-203. PubMed ID: 11572166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]